These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37649079)

  • 1. Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy.
    He C; Yang C; Zeng Q; Liu Z; Wang F; Chen Q; Liu T
    Stem Cell Res Ther; 2023 Aug; 14(1):224. PubMed ID: 37649079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
    Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
    Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia.
    Lan Y; Liu F; Chang L; Liu L; Zhang Y; Yi M; Cai Y; Feng J; Han Z; Han Z; Zhu X
    BMC Pediatr; 2021 Feb; 21(1):102. PubMed ID: 33639900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model.
    Gholampour MA; Abroun S; Nieuwland R; Mowla SJ; Soudi S
    J Cell Physiol; 2021 Aug; 236(8):6055-6067. PubMed ID: 33492726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro expansion of the adult human bone marrow mesenchymal stem cells for clinic application in HSCT].
    Kuang WY; Zhou XF; Zhang GS; Liu LH; Chen SF; Li RJ; Xiao L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):633-8. PubMed ID: 18549644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a defined xeno-free medium on the growth and neurotrophic and angiogenic properties of human adult stem cells.
    Brohlin M; Kelk P; Wiberg M; Kingham PJ
    Cytotherapy; 2017 May; 19(5):629-639. PubMed ID: 28366194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.
    Antoon R; Yeger H; Loai Y; Islam S; Farhat WA
    J Biomed Mater Res A; 2012 Jan; 100(1):72-83. PubMed ID: 21972045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia.
    Huo J; Zhang L; Ren X; Li C; Li X; Dong P; Zheng X; Huang J; Shao Y; Ge M; Zhang J; Wang M; Nie N; Jin P; Zheng Y
    Stem Cell Res Ther; 2020 Feb; 11(1):59. PubMed ID: 32054519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulation of umbilical cord blood mesenchymal stem cells on Treg cells in the patients with aplastic anemia].
    Cao YN; Zhou F; Song NX; Fang Y; Guan R
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2678-2681. PubMed ID: 28910956
    [No Abstract]   [Full Text] [Related]  

  • 12. High-efficient generation of VCAM-1
    Wei Y; Zhang L; Chi Y; Ren X; Gao Y; Song B; Li C; Han Z; Zhang L; Han Z
    Cell Prolif; 2020 Aug; 53(8):e12862. PubMed ID: 32597552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells.
    Al-Saqi SH; Saliem M; Asikainen S; Quezada HC; Ekblad A; Hovatta O; Le Blanc K; Jonasson AF; Götherström C
    Cytotherapy; 2014 Jul; 16(7):915-26. PubMed ID: 24726655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study.
    Swamynathan P; Venugopal P; Kannan S; Thej C; Kolkundar U; Bhagwat S; Ta M; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2014 Jul; 5(4):88. PubMed ID: 25069491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions.
    Gottipamula S; Ashwin KM; Muttigi MS; Kannan S; Kolkundkar U; Seetharam RN
    Cell Tissue Res; 2014 Apr; 356(1):123-35. PubMed ID: 24448665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Development of Umbilical Cord-Derived Mesenchymal Stem Cells During Long-Term Maintenance in Fetal Bovine Serum-Supplemented Medium and Xeno- and Serum-Free Culture Medium.
    Le HM; Nguyen LT; Hoang DH; Bach TQ; Nguyen HTN; Mai HT; Trinh DP; Nguyen TD; Nguyen LT; Than UTT
    Cell Reprogram; 2021 Dec; 23(6):359-369. PubMed ID: 34748399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanism of bone marrow-derived mesenchymal stem cells excessive senescence in severe aplastic anemia mouse model].
    Ou YQ; Liu HY; Lu W; Wen MJ; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):325-329. PubMed ID: 28468095
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2.
    Zhang Z; Huang S; Wu S; Qi J; Li W; Liu S; Cong Y; Chen H; Lu L; Shi S; Wang D; Chen W; Sun L
    EBioMedicine; 2019 Jul; 45():341-350. PubMed ID: 31248835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.